Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indevus Pharmaceuticals
Lexington, Massachusetts, United Statesinterneuron.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Prior to its acquisition by Endo Pharmaceuticals in March 2009, Indevus had a robust portfolio focused on urology and endocrinology with several FDA-approved products on the market for overactive bladder, prostate cancer, and central precocious puberty. The company was also pursuing regulatory approval for drugs targeting male hypogonadism and bladder cancer. Its pipeline included both proprietary small molecules and novel drug-delivery systems.[1][2]
- Therapeutic areas
- OncologyMen's HealthEndocrinologyUrology
- Modalities
- Small molecules[2]Drug-delivery implants[3]Biodegradable stents[3]
- Industry
- Biotech
02
Partnerships
Not specifically detailed in search results.
Beyond the preview
Go deeper on Indevus Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Indevus Pharmaceuticals.